RNS Number : 3156G
JPMorgan Elect PLC
14 November 2022
 

JPMORGAN ELECT PLC  (the 'Company')

 

Legal Entity Identifier: 549300FIUYKKL39ILD07


THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 31 October 2022


Managed Growth portfolio

 

JPMorgan American Inv Trust

14.8%

JPMorgan Claverhouse Inv Trust

8.2%

JPM UK Equity Plus C

7.9%

Finsbury Growth & Income

7.4%

JPMorgan UK Dynamic C

6.9%

JPMorgan US Equity All Capital C

6.3%

JPMorgan US Value Fund

4.1%

Murray Income Trust

3.6%

JPMorgan US Select Equity C

3.5%

Fidelity

3.3%

Total

66.0%

Excludes Investments in Liquidity stocks


Managed Income portfolio

 

Shell

9.0%

AstraZeneca

7.7%

BP

6.2%

Glencore

4.0%

British American Tobacco

4.0%

Barclays

3.1%

GSK

3.1%

BAE Systems Plc

2.6%

OSB

2.6%

Unilever

2.4%

Total

44.6%

Excludes Investments in Liquidity stocks


* Based on invested portfolio


Name of contact and telephone number for queries:


Paul Ainger 0044 207 742 6524


Name of authorised company official responsible for making this notification:


Priyanka Vijay Anand 0044 203 493 1504 - Company Secretary


Date: 14 November 2022





This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUUSRARUBUAAAA